HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

FP 21399

structure given in first source

Also Known As:

FP-21399

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        FP 21399: 5
      - Benzene Derivatives: 17
        Chlorobenzenes: 5
        FP 21399: 5
  - Halogenated Hydrocarbons: 42
    - Chlorinated Hydrocarbons: 240
      - Chlorobenzenes: 5
        FP 21399: 5
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - FP 21399: 5

Experts

1.	Ono, M: 2 articles (09/2000 - 08/2000)
2.	Yamaguchi, N: 2 articles (09/2000 - 08/2000)
3.	Poli, G: 1 article (11/2001)
4.	Vicenzi, E: 1 article (11/2001)
5.	Dahl, T: 1 article (09/2000)
6.	Gillies, S: 1 article (09/2000)
7.	Chapman, B: 1 article (08/2000)
8.	Chen, L B: 1 article (08/2000)
9.	Crumpacker, C S: 1 article (08/2000)
10.	Dahl, T A: 1 article (08/2000)

Related Diseases

1.	HIV Infections (HIV Infection) 11/01/2001 - "Lexigen (formerly Fuji ImmunoPharmaceuticals) is developing FP-21399, a bis-azo compound, for the potential treatment of HIV infections. " 09/01/2000 - "Liquid chromatographic determination of FP-21399 in plasma of patients with HIV infection." 08/01/2000 - "FP-21399 is a bis(disulfonaphthalene) derivative that prevents human immunodeficiency virus (HIV) infection of uninfected cells by blocking entry of the virus. "
2.	Infections 05/10/1998 - "The bis-azo compound FP-21399 inhibits HIV-1 infection. " 04/01/1997 - "In SCID mice reconstituted with human immune cells, maintenance of HIV-1 infection was blocked by a 5-day treatment with low doses of FP-21399, suggesting that lymph node accumulation may contribute to antiviral activity. "

Related Drugs and Biologics

1.	Antiviral Agents (Antivirals)